Gå direkt till innehåll

Pressmeddelande -

Emplicure and OnDosis announce partnership to develop better pain treatments

Emplicure AB och OnDosis AB utvärderar gemensamma utvecklingsmål för oral dosering av aktiva substanser baserade på bolagens respektive unika teknologier inom formulering och dosering.

Ämnen


Founded as a spin-out from AstraZeneca in 2017, OnDosis is a Swedish start-up addressing one of the major opportunities in healthcare; personalized dosage of medicines. The proprietary technology platform is centered around a connected handheld dosing device that delivers tailored doses of oral medicines. By combining individual dosing of traditional drug-based medicines augmented by digital therapeutics, OnDosis opens a new chapter in personalized medicine where the mission is to improve patients’ life through delivering the perfect dosage; individualized, intuitive, and intelligent.

Kontakter

  • Emplicure and OnDosis 230120.pdf
    Emplicure and OnDosis 230120.pdf
    Licens:
    All rights reserved
    Filformat:
    .pdf